v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Operating Activities:    
Net (loss) income $ (42,376,000) $ 22,900,000
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:    
Depreciation 790,000 905,000
Amortization of intangible assets and capitalized software development costs 13,251,000 14,699,000
Amortization of deferred costs to obtain revenue contracts 2,471,000 2,795,000
Gain on sale of businesses (Note 4) (16,585,000) (71,599,000)
Non-cash operating lease expense 1,470,000 1,567,000
Stock-based compensation 10,975,000 13,885,000
Other non-cash expenses   4,000
Bad debt expense 316,000 201,000
Change in fair value of acquisition contingent consideration   (4,000)
Unrealized loss on securities 67,000 95,000
Change in fair value of financial instruments 7,900,000 3,174,000
Deferred income taxes (1,288,000) (838,000)
Paid-in-kind interest, net 4,201,000 5,995,000
Non-cash interest expense 2,602,000 2,244,000
Loss on debt extinguishment, net 7,958,000  
Changes in operating assets and liabilities:    
Accounts receivable, net 1,072,000 4,149,000
Prepaid expenses and other current assets (1,384,000) (1,429,000)
Costs capitalized to obtain revenue contracts, net (1,742,000) (2,155,000)
Other non-current assets (7,000) 163,000
Accounts payable and accrued expenses (74,000) (3,047,000)
Deferred revenue 3,510,000 4,796,000
Customer deposits (772,000) (928,000)
Other current liabilities (999,000) 1,082,000
Contingent liabilities from acquisitions, net of current portion   (13,000)
Operating lease liabilities (2,327,000) (2,538,000)
Other non-current liabilities (193,000) (53,000)
Net cash used in operating activities (11,164,000) (3,950,000)
Investing Activities:    
Capital expenditures (5,561,000) (6,875,000)
Cash proceeds from the sale of businesses, net (Note 4) 46,913,000 91,384,000
Net cash provided by investing activities 41,352,000 84,509,000
Financing Activities:    
Proceeds from long-term debt, net of issuance costs 100,985,000 801,000
Principal payments of long-term debt (128,353,000) (65,781,000)
Payment of deferred financing costs (5,273,000) (7,068,000)
Proceeds from exercise of stock options and employee stock purchase plan purchases 275,000 474,000
Net cash used in financing activities (32,366,000) (71,574,000)
Effects of exchange rates on cash 52,000 86,000
Net change in cash, cash equivalents, and restricted cash (2,126,000) 9,071,000
Cash, cash equivalents, and restricted cash, beginning of period 29,454,000 17,300,000
Cash, cash equivalents, and restricted cash, end of period 27,328,000 26,371,000
Supplemental Noncash Investing and Financing Activities:    
Issuance of common stock for conversion of debt and interest 1,902,000 10,934,000
Amounts held in escrow related to the sale of businesses 738,000 285,000
Property and equipment purchases included in accounts payable 67,000 74,000
Supplemental Cash Flow Activities:    
Cash paid for interest 7,360,000 11,723,000
Cash paid for taxes $ 999,000 $ 277,000